Management


Peter Llewellyn-Davies
Chief Executive Officer, Chief Financial Officer (CEO/CFO)
Current:
Non Executive Board Member of Shield Therapeutics plc and Expedeon AG,
Founder of Accellerate Partners
Previous:
CFO/CBO Medigene, CFO Wilex, interim CFO Suppremol,
non-executive board member Immunocore and Catherex

Anderson Gaweco, M.D.,Ph.D.
Chief Medical Officer, Chief Scientific Officer (CMO/CSO)
Current:
Founder Innovimmune
Adjunct Professor, Georgetown University Medical Center
Guest Faculty, Georgetown Biotechnology Program
Previous:
Industry: CEO/CSO: Innovimmune, CMO: Lifecycle Pharma,
Global Clinical Leader: Roche & Pfizer, Sr Medical Scientist: AstraZeneca
Academia: Visiting Professor of Medicine: SUNY Medical Center,
Asst Professor of Medicine & Pathology: Loyola University Chicago